These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10624564)

  • 1. Driving drug discovery and patient therapy via the encapsulation and fusion of knowledge.
    Collins MA; Shaw I; Billington DC
    Drug Des Discov; 1999 Nov; 16(3):181-94. PubMed ID: 10624564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
    Levin M
    Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the discovery organization for innovation.
    Sams-Dodd F
    Drug Discov Today; 2005 Aug; 10(15):1049-56. PubMed ID: 16055021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of fragment-based drug design: strategic advances and lessons learned.
    Hajduk PJ; Greer J
    Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge-based approaches in the design and selection of compound libraries for drug discovery.
    Viswanadhan VN; Balan C; Hulme C; Cheetham JC; Sun Y
    Curr Opin Drug Discov Devel; 2002 May; 5(3):400-6. PubMed ID: 12058615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helping science to succeed: improving processes in R&D.
    Sewing A; Winchester T; Carnell P; Hampton D; Keighley W
    Drug Discov Today; 2008 Mar; 13(5-6):227-33. PubMed ID: 18342798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beginning to manage drug discovery and development knowledge.
    Sumner-Smith M
    Curr Opin Drug Discov Devel; 2001 May; 4(3):319-24. PubMed ID: 11560065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mergers and acquisitions on drug discovery: perspective from a case study of a Japanese pharmaceutical company.
    Shibayama S; Tanikawa K; Fujimoto R; Kimura H
    Drug Discov Today; 2008 Jan; 13(1-2):86-93. PubMed ID: 18190869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.
    Adam M
    Stud Hist Philos Biol Biomed Sci; 2005 Sep; 36(3):513-37. PubMed ID: 16137601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 1. Criticisms faced by the pharmaceutical industry.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2013 Jul; 56(14):5659-72. PubMed ID: 23557017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative business models for drug discovery.
    Bunin BA; Ekins S
    Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.
    Matter A; Keller TH
    Drug Discov Today; 2008 Apr; 13(7-8):347-52. PubMed ID: 18405848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unbalanced portfolio.
    Federsel HJ
    Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in knowledge management for pharmaceutical research and development.
    Torr-Brown S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical industry's corporate social responsibility towards HIV/AIDS.
    Khanna AK
    J Postgrad Med; 2006; 52(3):194-6. PubMed ID: 16855320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart drug discovery leveraging innovative technologies and predictive knowledge.
    Sawyer TK
    Nat Chem Biol; 2006 Dec; 2(12):646-8. PubMed ID: 17108975
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug development and the FDA's Critical Path Initiative.
    Woosley RL; Cossman J
    Clin Pharmacol Ther; 2007 Jan; 81(1):129-33. PubMed ID: 17186012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.